chemoradiotherapy

Documents about chemoradiotherapy

• Surgery Plus Reduced Target Chemoradiotherapy vs Surgery Plus Reduced Dose Chemoradiotherapy for Newly Diagnosed Operable Nasopharyngeal Carcinoma.#881713ClinicalTrials.gov
• Vestibular Function After Chemoradiotherapy for Nasopharyngeal Carcinoma#902841ClinicalTrials.gov
• Concurrent Chemoradiotherapy Followed by PD-1 Inhibitor in Advanced Cervical Cancer#184849ClinicalTrials.gov
• Endostar Combined With Concurrent Chemoradiotherapy For Locally Advanced Cervical Carcinoma#916676ClinicalTrials.gov
• Camrelizumab Plus Neoadjuvant Chemotherapy or Chemoradiotherapy Versus Chemoradiotherapy in Resectable ESCC.#981186ClinicalTrials.gov
• Chemoradiotherapy Followed by Planned Surgery or by Surveillance and Surgery Only When Needed for Oesophageal Cancer#896867ClinicalTrials.gov
• Induction Chemotherapy Followed by IMRT or Concurrent Chemoradiotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma#838862ClinicalTrials.gov
• Sintilimab After Concurrent Chemoradiotherapy in Elderly Patients With Esophageal Squamous Cell Carcinoma#217028ClinicalTrials.gov
• Enriched-CRT 2017: Advanced Gastric Cancer With LN+ and LVI+, Chemotherapy vs. Chemoradiotherapy#890898ClinicalTrials.gov
• Hypofractionated Chemoradiotherapy for Cervical Cancer#897302ClinicalTrials.gov
• Chemoradiotherapy and Anti-PD-1 Antibody in Anal Squamous Cell Cancer：Chase#908441ClinicalTrials.gov
• Nimotuzumab Combined With Chemoradiotherapy Versus Chemoradiotherapy for Local Advanced Cervical Squamous Cell Carcinoma#836192ClinicalTrials.gov
• Early Nutritional Intervention in NPC Patients Undergoing Concurrent Chemoradiotherapy#898805ClinicalTrials.gov
• Immunotherapy Combined With Chemoradiotherapy for First-line Treatment of Esophageal Squamous Cell Carcinoma（ChinECR）#802422ClinicalTrials.gov
• Cetuximab/Paclitaxel/Cisplatin Concurrent Chemoradiotherapy Followed by Esophagectomy for Loco-regional Esophageal Cancer#802689ClinicalTrials.gov
• Concurrent Chemoradiotherapy With Famitinib for Patients With Locally Advanced Nasopharyngeal Carcinoma#970011ClinicalTrials.gov
• Nimotuzumab Concurrent With Chemoradiotherapy for Esophageal Cancer Patients#801394ClinicalTrials.gov
• Hypofractionated Whole Pelvic Chemoradiotherapy With iRex Optimization in Cervical Cancer#806461ClinicalTrials.gov
• Perioperative Chemoradiotherapy for Potentially Resectable Gastric Cancer#830131ClinicalTrials.gov
• Serplulimab Plus Chemoradiotherapy for Stage III-IVA Cervical Cancer#834513ClinicalTrials.gov
• Phase II Trial of Thalidomide Combined With Concurrent Chemoradiotherapy in Esophageal Cancer#893410ClinicalTrials.gov
• A Study of Adebrelimab Combined With Chemoradiotherapy in the Treatment of Esophageal Small Cell Carcinoma#839825ClinicalTrials.gov
• Induction Chemoimmunotherapy Combined With Chemoradiotherapy in Esophageal Cancer#858739ClinicalTrials.gov
• PD-1 Antibody Plus Chemoradiotherapy for IB2-IIIB Cervical Cancer#121352ClinicalTrials.gov
• Study of PD-1 Antibody Combined With Chemoradiotherapy in Oligometastatic Esophageal Cancer#448273ClinicalTrials.gov
• Lipotecan Based Concurrent Chemoradiotherapy in Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis#847205ClinicalTrials.gov
• Induction Chemotherapy Followed by Radiotherapy Alone or Concurrent Chemoradiotherapy in Nasopharyngeal Carcinoma#886438ClinicalTrials.gov
• A Phase II Study of Postoperative S-1-Based Chemoradiotherapy in Gastric Cancer#903836ClinicalTrials.gov
• A Prospective Phase II Study of Individualized Neoadjuvant Chemoradiotherapy for Rectal Cancer Based on Recurrence Risk#842536ClinicalTrials.gov
• Whole-course Immunonutrition Combined With Chemoradiotherapy±ICIs for Local Advanced Patients With Inoperable Esophageal Squamous Cell Carcinoma#863872ClinicalTrials.gov
• Endoscopic Ultrasound Predict the Sensitivity of Stage II / III Rectal Cancer Preoperative Concurrent Chemoradiotherapy#890411ClinicalTrials.gov
• Neoadjuvant Sintilimab Plus Chemoradiotherapy for Locally Advanced Adenocarcinoma of Esophagogastric Junction#411405ClinicalTrials.gov
• Nimotuzumab Concurrent With Chemoradiotherapy for Patients With Unresectable Esophageal Squamous Cell Carcinoma#836922ClinicalTrials.gov
• Phase II Study of Postoperative Concurrent Chemoradiotherapy for Esophageal Squamous Cell Carcinoma (ESO- Shanghai 17)#863632ClinicalTrials.gov
• Safety Study of Docetaxel/Cisplatin Induction Therapy Followed by Concurrent Chemoradiotherapy or Concurrent Chemoradiotherapy Followed by Consolidation Docetaxel/Cisplatin in NSCLC Patients#966442ClinicalTrials.gov
• Effect of Immunonutrients on Oral Mucositis in Nasopharyngeal Carcinoma Patients After Chemoradiotherapy#805754ClinicalTrials.gov
• Prevalence of Obstructive Sleep Apnea Hypopnea Syndrome (OSAHS) Following Squamous Cell Carcinomas of the Oropharynx Treatment by Combined Chemoradiotherapy#906577ClinicalTrials.gov
• Comparison of Chemoradiotherapy and Chemoradiotherapy Combined With Consolidation Chemotherapy for ESCC#979950ClinicalTrials.gov
• Concurrent Chemoradiotherapy Combined With Toripalimab and Surufatinib in the Treatment of Limited-Stage Small Cell Lung Cancer#287563ClinicalTrials.gov
• Endostar in Combination With Chemoradiotherapy in Patient With Advanced Non-small Cell Lung Cancer#805819ClinicalTrials.gov
• Study of Chemoradiotherapy With Envafolimab For The Treatment of Locally Advanced Cervical Cancer#881968ClinicalTrials.gov
• Total Neoadjuvant Treatment vs. Chemoradiotherapy in Local Advanced Rectal Cancer With High Risk Factors#897555ClinicalTrials.gov
• Study Compare Adjuvant Chemotherapy, Chemoradiotherapy and Surgery Alone for pN1-2(pT1b-3N1-2M0) Esophageal Carcinoma#907672ClinicalTrials.gov
• Preoperative Chemoradiotherapy and Transanal Endoscopic Microsurgery Versus Total Mesorectal Excision in T2-T3s N0, M0 Rectal Cancer#991934ClinicalTrials.gov
• PD-1 Inhibitors Plus Chemoradiotherapy for Metastatic Nasopharyngeal Carcinoma: an Open-label Single-arm, Phase II Trial#806839ClinicalTrials.gov
• Study of Split-course Chemoradiotherapy For Postoperative Locoregional Recurrence Of Non-small Cell Lung Cancer#855496ClinicalTrials.gov
• To Compare the Effect of Different Nutritional Pathways on Improving Nutritional Status of Esophageal Cancer Patients Undergoing Chemoradiotherapy#905798ClinicalTrials.gov
• Baseline hemoglobin <11.0 g/dL has stronger prognostic value than anemia status in nasopharynx cancers treated with chemoradiotherapy#955594Koc University Digital Collections
• Combination of Toripalimab and Chemoradiotherapy in Esophageal Cancer#349942ClinicalTrials.gov
• A Study of Carilizumab Combined With Concurrent Chemoradiotherapy#471445ClinicalTrials.gov